COVID-19 Infection in Cancer Patients: How Can Oncologists Deal With These Patients?

Antonio Russo, Antonio Galvano, Behzad Baradaran, Oronzo Brunetti, Afshin Derakhshani, Nicola Silvestris

Research output: Contribution to journalArticlepeer-review

19 Citations (Scopus)

Abstract

The world is facing a new pandemic caused by a novel beta coronavirus (COVID 19), which causes severe respiratory coronavirus syndrome (SARS-CoV-2). Unfortunately, there are currently no US Food and Drug Administration (FDA) approved medications for the treatment of COVID-19 patients. High mortality rates in frail patients is a notable feature of the virus registered since the onset of COVID-19 pandemic. Above all, elderly patients or those with underlying chronic illnesses and compromised immune system are most at risk (1). Thus, the consideration is that the possible coexistence, in the same individual, of a cancer diagnosis and a COVID-19 infection could generate a synergistic negative prognostic effect.
Original languageEnglish
Number of pages3
JournalFrontiers in Oncology
Volume10
Publication statusPublished - 2020

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'COVID-19 Infection in Cancer Patients: How Can Oncologists Deal With These Patients?'. Together they form a unique fingerprint.

Cite this